Elevated osteoprotegerin is associated with abnormal ankle brachial indices in patients infected with HIV: A cross-sectional study

Journal of the International AIDS Society

Volumn 13, Issue 1, 2010, Pages

  Jang, James J ^a   Schwarcz, Aron I ^a   Amaez, Daniel A ^a   Woodward, Mark ^a   Olin, Jeffrey W ^a   Keller, Marla J ^a   Schecter, Alison D ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; OSTEOPROTEGERIN;

ADULT; ANKLE BRACHIAL INDEX; ARTICLE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; GROUPS BY AGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; MAJOR CLINICAL STUDY; MEDICAL HISTORY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; URBAN AREA; VASCULITIS; BLOOD; CROSS-SECTIONAL STUDY; FEMALE; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASE; RISK FACTOR;

ADULT; ANKLE BRACHIAL INDEX; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; OSTEOPROTEGERIN; PERIPHERAL VASCULAR DISEASES; RISK FACTORS;

EID: 78650215291     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.1186/1758-2652-13-12     Document Type: Article

References (36)

1. Joint United Nations Programme on HIV/AIDS and World Health Organization, 2007 AIDS Epidemic Update. December Geneva 2007
2. HIV infection, highly active antiretroviral therapy and the cardiovascular system. Barbaro G, Cardiovasc Res 2003 60 1 87 95 10.1016/S0008-6363(02)00828-3 14522410 (Pubitemid 38373479)
3. Peripheral arterial disease in HIV-infected and uninfected women. Sharma A, Holman S, Pitts R, Minkoff HL, Dehovitz JA, Lazar J, HIV Med 2007 8 8 555 60 10.1111/j.1468-1293.2007.00509.x 17944689 (Pubitemid 47616835)
4. High prevalence of peripheral arterial disease in HIV-infected persons. Periard D, Cavassini M, Taffé P, Chevalley M, Senn L, Chapuis-Taillard C, de Vallière S, Hayoz D, Tarr PE, Swiss HIV Cohort Study, Clin Infect Dis 2008 46 5 761 7 10.1086/527564 18230043 (Pubitemid 351321563)
5. Peripheral arterial disease in HIV patients older than 50 years of age. Palacios R, Alonso I, Hidalgo A, Aguilar I, Sánchez MA, Valdivielso P, González-Santos P, Santos J, AIDS Res Hum Retroviruses 2008 24 8 1043 6 10.1089/aid.2008.0001 18620492
6. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor- associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA, Lancet 1999 353 2093 9 10.1016/S0140-6736(98)08468-2 10382692 (Pubitemid 29278477)
7. HIV protease inhibitors promote atherosclerotic lesion formation independent of dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in macrophages. Dressman J, Kincer J, Matveev SV, Guo L, Greenberg RN, Guerin T, Meade D, Li XA, Zhu W, Uittenbogaard A, Wilson ME, Smart EJ, J Clin Invest 2003 111 3 389 97 12569165 (Pubitemid 36182216)
8. HIV envelope gp120 activates human arterial smooth muscle cells. Schecter AD, Berman AB, Yi L, Mosoian A, McManus CM, Berman JW, Klotman ME, Taubman MB, Proc Natl Acad Sci USA 2001 98 18 10142 7 10.1073/pnas.181328798 11504923 (Pubitemid 32802988)
9. Ankle-branch index and HIV: the role of antiretrovirals. Olalla J, Salas D, Del Arco A, De la Torre J, Prada J, Machín-Hamalainen S, García-Alegría J, HIV Med 2009 10 1 1 5 10.1111/j.1468-1293.2008. 00638.x 18795963
10. American Heart Association, Heart Disease and Stroke Statistics 2004 Update. Dallas, Texas 2003
11. Mandate for creation of a national peripheral arterial disease public awareness program: an opportunity to improve cardiovascular health. Hirsch AT, Gloviczki P, Drooz A, Lovell M, Creager MA, Board of Directors of the Vascular Disease Foundation, J Vasc Surg 2004 39 2 474 81 10.1016/j.jvs.2003.09.028 14743158 (Pubitemid 38174339)
12. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Resnick HE, Lindsay RS, McDermott MM, Devereux RB, Jones KL, Fabsitz RR, Howard BV, Circulation 2004 109 733 739 10.1161/01.CIR.0000112642.63927.54 14970108 (Pubitemid 38222892)
13. Atherosclerosis - an inflammatory disease. Ross R, N Engl J Med 1999 340 2 115 26 10.1056/NEJM199901143400207 9887164 (Pubitemid 29054847)
14. RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function. Schoppet M, Preissner KT, Hofbauer LC, Arterioscler Thromb Vasc Biol 2002 22 4 549 53 10.1161/01.ATV.0000012303.37971.DA 11950689 (Pubitemid 34408732)
15. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Lüthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ, Cell 1997 89 2 309 19 10.1016/S0092-8674(00)80209-3 9108485 (Pubitemid 27199902)
16. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS, Genes Dev 1998 12 9 1260 8 10.1101/gad.12.9.1260 9573043 (Pubitemid 28213402)
17. Osteoprotegerin, vascular calcification and atherosclerosis. Van Campenhout A, Golledge J, Atherosclerosis 2008 204 2 321 329 10.1016/j.atherosclerosis.2008.09.033 19007931
18. Serum osteoprotegerin is increased and independently associated with coronary-artery atherosclerosis in patients with rheumatoid arthritis. Asanuma Y, Chung CP, Oeser A, Solus JF, Avalos I, Gebretsadik T, Shintani A, Raggi P, Sokka T, Pincus T, Stein CM, Atherosclerosis 2007 195 2 135 41 10.1016/j.atherosclerosis.2007.04.049 17570371 (Pubitemid 350087969)
19. Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease. Kiechl S, Schett G, Wenning G, Redlich K, Oberhollenzer M, Mayr A, Santer P, Smolen J, Poewe W, Willeit J, Circulation 2004 109 18 2175 80 10.1161/01.CIR.0000127957.43874.BB 15117849 (Pubitemid 38625393)
20. Osteoprotegerin plasma concentrations correlate with severity of peripheral artery disease. Ziegler S, Kudlacek S, Luger A, Minar E, Atherosclerosis 2005 182 1 175 80 10.1016/j.atherosclerosis.2005.01.042 16115489 (Pubitemid 41188384)
21. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001 285 2486 97 10.1001/jama.285.19.2486 11368702
22. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Newman AB, Shemanski L, Manolio TA, Cushman M, Mittelmark M, Polak JF, Powe NR, Siscovick D, Arterioscler Thromb Vasc Biol 1999 19 538 545 10073955 (Pubitemid 29135153)
23. Peripheral arterial disease in the elderly: The Rotterdam Study. Meijer WT, Hoes AW, Rutgers D, Bots ML, Hofman A, Grobbee DE, Arterioscler Thromb Vasc Biol 1998 18 185 192 9484982 (Pubitemid 28277594)
24. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Fowkes FG, Housley E, Cawood EH, Macintyre CC, Ruckley CV, Prescott RJ, Int J Epidemiol 1991 20 384 392 10.1093/ije/20.2.384 1917239
25. Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. Zheng ZJ, Sharrett AR, Chambless LE, Rosamond WD, Nieto FJ, Sheps DS, Dobs A, Evans GW, Heiss G, Atherosclerosis 1997 131 1 115 25 10.1016/S0021-9150(97)06089-9 9180252 (Pubitemid 27240104)
26. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Selvin E, Erlinger TP, Circulation 2004 110 6 738 43 10.1161/01.CIR.0000137913.26087.F0 15262830 (Pubitemid 39056275)
27. Ankle-brachial index and subclinical cardiac and carotid disease: the multi-ethnic study of atherosclerosis. McDermott MM, Liu K, Criqui MH, Ruth K, Goff D, Saad MF, Wu C, Homma S, Sharrett AR, Am J Epidemiol 2005 162 1 33 41 10.1093/aje/kwi167 15961584 (Pubitemid 40884998)
28. Prediction of coronary heart disease using risk factor categories. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB, Circulation 1998 97 18 1837 47 9603539 (Pubitemid 28213628)
29. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Newman AB, Siscovick DS, Manolio TA, Polak J, Fried LP, Borhani NO, Wolfson SK, Circulation 1993 88 837 845 8353913 (Pubitemid 23263998)
30. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM Jr, White CJ, White J, White RA, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B, Circulation 2006 113 11 463 654 10.1161/CIRCULATIONAHA.106.174526 16549646
31. Jang J, Olin J, Medical Therapy of Peripheral Vascular Disease. Hemostasis and Thrombosis: Basic Principles & Clinical Practice Lippincott, Williams & Wilkins; Philadelphia, PA 5 2006
32. Relation of inflammation to peripheral arterial disease in the national health and nutrition examination survey, 1999-2002. Wildman RP, Muntner P, Chen J, Sutton-Tyrrell K, He J, Am J Cardiol 2005 96 11 1579 83 10.1016/j.amjcard. 2005.07.067 16310445 (Pubitemid 41690183)
33. Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes. Omland T, Ueland T, Jansson AM, Persson A, Karlsson T, Smith C, Herlitz J, Aukrust P, Hartford M, Caidahl K, J Am Coll Cardiol 2008 51 6 627 33 10.1016/j.jacc.2007.09.058 18261681 (Pubitemid 351193104)
34. Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study). Abedin M, Omland T, Ueland T, Khera A, Aukrust P, Murphy SA, Jain T, Gruntmanis U, McGuire DK, de Lemos JA, Am J Cardiol 2007 99 4 513 8 10.1016/j.amjcard.2006.08.064 17293196 (Pubitemid 46215559)
35. RANKL/OPG/TRAIL plasma levels and bone mass loss evaluation in antiretroviral naive HIV-1-positive men. Gibellini D, Borderi M, De Crignis E, Cicola R, Vescini F, Caudarella R, Chiodo F, Re MC, J Med Virol 2007 79 10 1446 54 10.1002/jmv.20938 17705184 (Pubitemid 47328732)
36. Alterations in circulating osteoimmune factors may be responsible for high bone resorption rate in HIV-infected children and adolescents. Mora S, Zamproni I, Cafarelli L, Giacomet V, Erba P, Zuccotti G, Vigan A, AIDS 2007 21 9 1129 35 10.1097/QAD.0b013e32810c8ccf 17502723 (Pubitemid 46763283)